NEW YORK (

TheStreet

) --

Johnson & Johnson

(JNJ) - Get Report

was under pressure Friday as the medical products maker faces numerous lawsuits alleging it knowingly made problematic artificial hips.

J&J's DePuy Orthopaedics unit faces around 1,000 lawsuits claiming it continued to make metal-on-metal hips even after it knew the hips had faults, according to a report in

The Wall Street Journal

.

Production of the metal-on-metal hips was stopped in 2009, and any joints that remained available on the market were

recalled by J&J last year

.

>> 2011 Consumer Recall Alerts

J&J shares fell 0.7% to $67.45 on Friday.

Analysts at Wells Fargo estimated that J&J could be on the hook for $1 billion in liability and other costs related to the flood of lawsuits.

J&J, meanwhile, said its product-liability reserves were $570 million more than a year ago. The company also allotted a reserve of $280 million to specifically cover the medical costs of patients directly affected by the recalled artificial hips.

Stryker

(SYK) - Get Report

, a rival to J&J in the hip replacement space, saw its shares fall 1.4% to $59.78.

-- Written by Miriam Marcus Reimer in New York.

>To contact the writer of this article, click here:

Miriam Reimer

.

>To follow the writer on Twitter, go to

http://twitter.com/miriamsmarket

.

>To submit a news tip, send an email to:

tips@thestreet.com

.

READERS ALSO LIKE:

>> Bankruptcy Watch: 14 Risky Restaurant Stocks

>> Consumer Dividend Stocks Increasing Payouts

>> 14 REITs Increasing Dividends Annually

>> Dunkin' Donuts IPO Bound: Reports

>> 10 Top Dividend Stocks for 2011

>> Starbucks to Grow Grocery Business Tenfold

>> Consumer Products You Pay More For

>> Taco Bell to Offer Free Wi-Fi by 2015

>>See our new stock quote page.

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.